Anxiety and risk assessment-related traits in a rat model of Spinocerebellar ataxia type 17

Behav Brain Res. 2017 Mar 15:321:106-112. doi: 10.1016/j.bbr.2016.12.023. Epub 2016 Dec 23.

Abstract

Anxiety as a common feature of several neurodegenerative/polyglutamine diseases is an important aspect for the face validity of an animal model for Spinocerebellar Ataxia type 17 (SCA17). Risk assessment and anxiety-like traits were characterised in 3-6-9 months old rats of a transgenic model for SCA17 using the standard behavioural test elevated plus maze. In addition, c-Fos immunostainings in the basolateral amygdala evaluated neuronal activation in correlation to the behavioural responses. The most prominent behavioural effect was a higher level of risk assessment in the transgenic rats. In addition, an increase in anxiety-related behaviour in these rats was found. Although the EPM caused no overall effect on c-Fos expression, a negative correlation with the anxiety-like behavioural response was observed. Our results suggest that the SCA17 rat model displays an anxious phenotype already at 3 months of age resembling the generalized anxiety in early symptomatic SCA17 patients, thus confirming the validity of this rat model.

Keywords: C-Fos neuronal activation; Disease development; Elevated plus maze; Model characterization; Polyglutamine disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Anxiety* / metabolism
  • Anxiety* / pathology
  • Basolateral Nuclear Complex / metabolism
  • Basolateral Nuclear Complex / pathology
  • Exploratory Behavior
  • Immunohistochemistry
  • Male
  • Neurons / metabolism
  • Neurons / pathology
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats, Transgenic
  • Risk-Taking*
  • Spinocerebellar Ataxias / metabolism
  • Spinocerebellar Ataxias / pathology
  • Spinocerebellar Ataxias / psychology*

Substances

  • Proto-Oncogene Proteins c-fos

Supplementary concepts

  • Spinocerebellar Ataxia 17